12 Pulmonary Hypertension Clinical Trials in St. Petersburg, FL (2026)

Q: How do I join a clinical trial in St. Petersburg?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you.

Recruiting Pulmonary Hypertension Studies in St. Petersburg

NCT07246980Recruiting

Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study

is is a multi-center, open-label, observational registry study (both prospective and retrospective) designed to evaluate the safety and performance of the allay™ Hydrogel Cap. This cap is an in situ f...

St. Petersburg, FL1,000 participantsTulavi Therapeutics,Inc.

View Study Details

NCT05865301Recruiting

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

To use a consistent and standardized platform to retrospectively and prospectively study children and young adults with B cell malignancies receiving Immunotherapy, blinatumomab and/or inotuzumab ozog...

St. Petersburg, FL500 participantsStanford University

View Study Details

NCT05645107Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period will reduce the rate of major bacterial infections p...

St. Petersburg, FLPHASE3386 participantsGrifols Therapeutics LLC

View Study Details

NCT07179380Recruiting

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD....

St. Petersburg, FLPHASE3344 participantsInsmed Incorporated

View Study Details

NCT07441642Recruiting

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)....

St. Petersburg, FLPHASE2272 participantsNovartis Pharmaceuticals

View Study Details

NCT06163430Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

The goal of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of TERN-701, a highly selective allosteric inhibitor of BCR-ABL1, in participants with pr...

St. Petersburg, FLPHASE1180 participantsTerns, Inc.

View Study Details

NCT06428019Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the safety of venetoclax in combination with obinutuzumab or acalabrutini...

St. Petersburg, FLPHASE3170 participantsAbbVie

View Study Details

NCT05416307Recruiting

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Hemophagocytic lymphohistiocytosis is a rare, aggressive and life-threatening syndrome of excessive immune activation. Secondary hemophagocytic lymphohistiocytosis (sHLH) is the most common form of th...

St. Petersburg, FLPHASE2156 participantsElectra Therapeutics Inc.

View Study Details

NCT04920617Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refr...

St. Petersburg, FLPHASE2102 participantsImmunoVaccine Technologies, Inc. (IMV Inc.)

View Study Details

NCT05022459Recruiting

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Hemophilia A (HA) is a genetic bleeding disorder resulting from a deficiency or absence of factor VIII (FVIII), which is necessary in the clotting process. This disorder occurs mostly in males and in ...

St. Petersburg, FL72 participantsWayne State University

View Study Details

NCT06047977Recruiting

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Part One of this study will determine the feasibility of creating Tumor-Infiltrating Lymphocyte (TIL) product prospectively from high-risk pediatric solid tumors. Part Two of this study will determin...

St. Petersburg, FLPHASE130 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT04972942Recruiting

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell trans...

St. Petersburg, FLPHASE130 participantsNew York Medical College

View Study Details

About Pulmonary Hypertension Clinical Trials in St. Petersburg

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 12 pulmonary hypertension clinical trials recruiting participants in St. Petersburg, FL. These studies are seeking a combined 3,242 participants. Research is being sponsored by Tulavi Therapeutics,Inc., Stanford University, Grifols Therapeutics LLC and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in St. Petersburg — FAQ

Are there pulmonary hypertension clinical trials in St. Petersburg?

Yes, there are 12 pulmonary hypertension clinical trials currently recruiting in St. Petersburg, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St. Petersburg?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you about next steps.

Are clinical trials in St. Petersburg free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St. Petersburg studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 12 active trials in St. Petersburg are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 22, 2026 from ClinicalTrials.gov